CompletedNot Applicable

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study

Germany124 participantsStarted 2024-01-22

Plain-language summary

The main objective of this study is to investigate whether checklist-based close telephone consultation and process surveillance for S. aureus bacteraemia (SAB) can improve adherence to our in-house SAB-guidelines (prospective quality- improvement group). In addition, the effects of telephone consultation on the clinical outcome of patients will be examined.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥ 18 years * Inpatient treatment at the University Medicine Greifswald university hospital * First diagnosis of SAB in hospital Exclusion Criteria: * SAB already known before admission * Palliative management within 48 hrs after SAB diagnosis * Death within 48 hrs after SAB diagnosis * Hospital discharge within 48hrs after SAB diagnosis

What they're measuring

SOP adherence, calculated as a sum score per patient with the following 8 parameters:

Timeframe: Hospital admission until hospital discharge (no later than day 90 after diagnosis)

Trial details

NCT IDNCT06249451

SponsorUniversity Medicine Greifswald

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-19

View on ClinicalTrials.gov More Staphylococcus Aureus Bacteremia trials